Cargando…
Heparin Induced Thrombocytopenia in Patients with COVID-19
Background The Coronavirus disease-2019 (COVID-19) is a global pandemic caused by novel coronavirus SARS-CoV-2. Acute respiratory and renal failure as well as systemic coagulopathy are critical aspects of the morbidity and mortality in patients with COVID-19. Heparin Induced Thrombocytopenia (HIT) o...
Autores principales: | Warrior, Surbhi, Behrens, Elizabeth, Gezer, Sefer, Venugopal, Parameswaran, Jain, Shivi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330311/ http://dx.doi.org/10.1182/blood-2020-134702 |
Ejemplares similares
-
Immune Thrombocytopenia Associated with COVID-19 - Case Series
por: Fatkhullin, Ramil, et al.
Publicado: (2020) -
Does Thrombocytopenia Truly Correlate with COVID-19 Severity?
por: Hana, Caroline, et al.
Publicado: (2020) -
Thrombocytopenia Associated with Increase in Disease Severity and Mortality in COVID-19 Patients
por: Banwait, Ranjit, et al.
Publicado: (2020) -
Spontaneous Heparin-Induced Thrombocytopenia and COVID-19 Infection
por: Amara, Suneetha
Publicado: (2021) -
Thrombotic Microangiopathy Variants Are Independently Associated with Critical Disease in COVID-19 Patients
por: Gavriilaki, Eleni, et al.
Publicado: (2020)